Sema4D/Plexin-B1 increased the proliferative and invasive potential of LNCaP prostate cancer cells through the activation of ErbB2 and Akt, but decreased the motility and proliferation of PC3 prostate cells (65). This evidence concerns the gene SEMA4D and prostate carcinoma.